quality of life
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
11.03.2016
VICHY Announces the First Annual VICHY EXPOSOME GRANT
VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research […]
21.07.2015
Juvéderm® VOLIFT™ Retouch extends the VYCROSS™ Collection
Allergan Symposium at the 13. AMWC in Monaco: The day long symposium under the guidance of Dr. Koenraad de Boulle from Belgium was dedicated to the motto „Achieving real expressions […]

